KRAS and colorectal carcinoma: Of the 12 NTRK fusion-positive CRC and small intestine cases, 50% (N = 6) were MSI-H (Figure 6C) and 92% (N = 11) were KRAS, NRAS, and BRAF wild-type, consistent with published data (Cocco et al., 2019b).